Immunotherapy Resistance and Advancing Adaptive Cell Therapeutics

5,947
Total downloads
20k
Total views and downloads

Articles

ORIGINAL RESEARCH

Accepted on 31 Mar 2025

Advancing Personalized, Predictive, and Preventive Medicine (PPPM/3PM) in Bladder Cancer: A Multi-Omics and Machine Learning Approach for Novel Prognostic Modeling, Immune Profiling, and Therapeutic Target Discovery

Han Yan
Xinyu Ji
Bohan Li

doi 10.3389/fimmu.2025.1572034

MINI REVIEW

Published on 28 Mar 2025

γδT cells, a key subset of T cell for cancer immunotherapy

Jianzhen Lv
Zheng Liu
Xiangting Ren
Siyuan Song
Yan Zhang
Yi Wang

doi 10.3389/fimmu.2025.1562188

560 views

REVIEW

Published on 21 Mar 2025

New player in CAR-T manufacture field: comparison of umbilical cord to peripheral blood strategies

Karolina Rassek
Jan Misiak
Tomasz Ołdak
Natalia Rozwadowska
Grzegorz Basak
Tomasz Kolanowski

doi 10.3389/fimmu.2025.1561174

955 views

MINI REVIEW

Published on 12 Feb 2025

Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies

Jianyang Ao
Mingtai Hu
Jinghan Wang
Xiaoqing Jiang

doi 10.3389/fimmu.2025.1559465

1,329 views

MINI REVIEW

Published on 05 Feb 2025

Advancements in cellular immunotherapy: overcoming resistance in lung and colorectal cancer

Lijuan Qin
Yuan Li
Juan Liu
Xiaoqin An

doi 10.3389/fimmu.2025.1554256

1,732 views

REVIEW

Published on 14 Jan 2025

Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis

Zhiyong Wan
Meng Cui
Jia Yang
Dan Liao
Junliang Chen
Fanmin Li
Yin Xiang
Zhiwei Cui
Yang Yang

doi 10.3389/fonc.2024.1531219

469 views

REVIEW

Published on 29 Nov 2024

Breaking barriers: advancing cellular therapies in autoimmune disease management

Yanhong Fu
Chunjing Feng
Shan Qin
Zhiyao Xing
Chong Liu
Zichuan Liu
Hongjian Yu

doi 10.3389/fimmu.2024.1503099

1,979 views
1 citation

ORIGINAL RESEARCH

Published on 24 Jun 2024

CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma

Michael W. Moles
Henry Erdlei
Lutz Menzel
Marialucia Massaro
Agnese Fiori
Mario Bunse
Moritz Schrimpf
Kerstin Gerlach
Venugopal Gudipati
7 more
Armin Rehm

doi 10.3389/fimmu.2024.1383136

3,601 views
3 citations

CASE REPORT

Published on 11 Jun 2024

Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study

Laura Patton
Bethany Monteith
Paul Heffernan
Thomas Herzinger
Brooke E. Wilson

doi 10.3389/fonc.2024.1394543

1,346 views
2 citations

ORIGINAL RESEARCH

Published on 19 Apr 2024

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization

Heleen Hanssens
Fien Meeus
Yannick De Vlaeminck
Quentin Lecocq
Janik Puttemans
Pieterjan Debie
Timo W. M. De Groof
Cleo Goyvaerts
Kim De Veirman
1 more
Nick Devoogdt

doi 10.3389/fimmu.2024.1389018

2,777 views

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy
Vaccines and Molecular Therapeutics
T Cell Biology

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Impact

20kTopic views
13kArticle views
5,947Article downloads

View impact

Articles

Advancing Personalized, Predictive, and Preventive Medicine (PPPM/3PM) in Bladder Cancer: A Multi-Omics and Machine Learning Approach for Novel Prognostic Modeling, Immune Profiling, and Therapeutic Target Discovery

γδT cells, a key subset of T cell for cancer immunotherapy

New player in CAR-T manufacture field: comparison of umbilical cord to peripheral blood strategies

Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies

Advancements in cellular immunotherapy: overcoming resistance in lung and colorectal cancer

Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis

Breaking barriers: advancing cellular therapies in autoimmune disease management

CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma

Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Vaccines and Molecular Therapeutics

T Cell Biology

Participating Journals

Frontiers in Oncology

Cancer Immunity and Immunotherapy